Sales & Marketing Sponsored 12 Questions with Giuseppe Accogli Giuseppe Accogli became the Group CEO of Chiesi Pharmaceuticals in 2023.
Sales & Marketing Changing Faces: Pharma and biotech January 2025 Welcome to the first edition of Changing Faces for 2025.
Sales & Marketing Bluesky offers an opportunity pharma should not ignore As X becomes a battleground for increasingly polarised debate, its lesser-known (but strikingly similar) cousin Bluesky is rapidly gaining traction.
Sales & Marketing Sponsored Solution Spotlight: Viseven’s eWizard With the right process and tools, localisation can become a well-oiled machine.
Sales & Marketing Sponsored Solution Spotlight: Enavia Launch Excellence Enavia Launch Excellence is transforming pharma launches with data-driven insights, seamless collaboration, and lifecycle optimisation.
Sales & Marketing The "Wicked" prescription: Humanising healthcare marketing Wicked isn't just a beloved musical and blockbuster movie; it's a blueprint for impactful storytelling that resonates on a deeply human level.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
